CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for REVA Medical, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

REVA Medical, Inc.
5751 Copley Drive
Phone: (858) 966-3000p:858 966-3000 San Diego, CA  92111-7911  United States Fax: (858) 966-3099f:858 966-3099
This company ceased filing statements with the SEC on 3/5/2020.
This company is no longer actively traded on any major stock exchange.
Business Summary
REVA Medical, Inc. (REVA) is a pre-revenue-stage medical device company. The Company is engaged in commercialization of its technologies to provide minimally invasive medical devices for the treatment of conditions in the humans. The Company operates through the development and commercialization of medical devices segment. The Company is in the later stages of developing and clinically testing bioresorbable drug-eluting coronary stents, which are called as scaffolds. The Company's scaffolds combine its bioresorbable polymer with various designs, including conventional designs and internally developed designs. The Company's scaffolds features include x-ray visibility, clinical delivery, low profile and expansion range. The Company has developed, tested and selected the polymer formulation, tested and selected the anti-restenotic drug and coating process, created and iterated the device design, and identified and implemented methods and processes to produce and test the scaffold.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201812/31/2017YesYesYes--

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies
8731 Commercial physical and biological research
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Charles R.Larkin 9/18/2017 7/13/2017
President Jeffrey A.Anderson 50 3/27/2019 2/1/2011
Chief Financial Officer and Corporate Secretary LeighElkolli 1/4/2019 8/1/2017
6 additional Officers and Directors records available in full report.

Business Names
Business Name
REVA Germany GmbH
REVA Medical, Inc.
RVA

General Information
Number of Employees: 45 (As of 9/30/2018)
Outstanding Shares: 41,479,877 (As of 11/1/2018)
Shareholders: 800
Stock Exchange: ASX
Federal Tax Id: 330810505
Fax Number: (858) 966-3099
Email Address: info@revamedical.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023